Related Experiment Video
Updated: May 28, 2026
04:17
Determining the Serum Stability of Human Adenosine Deaminase 1 Enzyme
Published on: September 27, 2024
Recent perspectives into biochemistry of decavanadate
1FCT, University of Algarve, Gambelas, 8005-139 Faro, Portugal.
World Journal of Biological Chemistry
|October 28, 2011
Summary
Decameric vanadate (V(10)) exhibits distinct biochemical effects compared to monomeric vanadate (V(1)). Decavanadate shows promise as an antidiabetic and anticancer agent, though further research is needed.
Area of Science:
- Biochemistry
- Cell Biology
- Toxicology
Background:
- Research on decavanadate has doubled in the past decade.
- Decameric vanadate (V(10)) exhibits distinct properties and biological effects compared to monomeric vanadate (V(1)).
Purpose of the Study:
- To review new insights into decavanadate biochemistry, cell biology, and its potential antidiabetic and antitumor activities.
- To compare the biological effects of decavanadate (V(10)) with monomeric vanadate (V(1)).
Main Methods:
- Biochemical assays to assess effects on calcium pumps and actomyosin ATPase activity.
- In vitro studies on mitochondrial oxygen consumption and actin polymerization.
- In vivo toxicity studies and in vitro studies on rat and human adipocytes.
Main Results:
- Decavanadate inhibits calcium pump ATPase and actomyosin ATPase activity, unlike monomeric vanadate.
- Decavanadate prevents actin polymerization and interacts with actin, inducing cysteine oxidation.
- Decavanadate significantly affects mitochondrial oxygen consumption and increases glucose accumulation in rat adipocytes.
Conclusions:
- Decavanadate possesses unique biochemical properties and biological effects distinct from monomeric vanadate.
- Decavanadate demonstrates potential as a biochemical tool for antidiabetic and anticancer applications.
- Further studies are required to validate decavanadate and its complexes as therapeutic agents.
Related Concept Videos
01:16Drug Biotransformation: Overview
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
01:28Drug Biotransformation: Overview
Biotransformation, also known as drug metabolism, is a vital physiological process that chemically alters drugs, facilitating their elimination from the body and terminating their action. This process involves two main phases: phase I and phase II reactions. Phase I reactions, including oxidation, reduction, and hydrolysis, introduce or unmask polar functional groups on the drug molecule, thereby increasing its water solubility. By enhancing water solubility, the drug becomes more hydrophilic...
01:22Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug absorption...
01:15Carboxylic Acid Derivatives: Overview
Carboxylic acid derivatives are formed by replacing the hydroxyl group of carboxylic acids with a different functional group. The most common carboxylic acid derivatives are:
01:25Bioactivation and Tissue Toxicity
Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
01:28Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...